Treatment effects in prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Link
http://www.nature.com/articles/modpathol2017158.pdf
Reference54 articles.
1. Chen RC, Rumble RB, Loblaw DA et al. Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol 2016;34:2182–2190.
2. Lindner U, Lawrentschuk N, Weersink RA et al. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol 2010;57:1111–1114.
3. Perera M, Krishnananthan N, Lindner U et al. An update on focal therapy for prostate cancer. Nat Rev Urol 2016;13:641–653.
4. Mottet N, Bellmunt J, Bolla M et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2017;71:618–629.
5. Gravis G, Audenet F, Irani J et al. Chemotherapy in hormone-sensitive metastatic prostate cancer: evidences and uncertainties from the literature. Cancer Treat Rev 2017;55:211–217.
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Updated Review on Analysis of long Non-coding RNAs as Emerging Diagnostic and Therapeutic Targets in Prostate Cancers;Critical Reviews in Oncology/Hematology;2024-02
2. Curcumin inhibits prostate cancer by upregulating miR‐483‐3p and inhibiting UBE2C;Journal of Biochemical and Molecular Toxicology;2024-01-24
3. PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway;Cancer Biomarkers;2024-01-17
4. Prognostic significance of surgery and radiotherapy in elderly patients with localized prostate cancer: establishing and time-based external validation a nomogram from SEER-based study;BMC Urology;2024-01-06
5. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling;Journal of Translational Medicine;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3